Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 7/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | AR | P10275 | 1/20 | 0.61 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.60 |
| ▸ | CA1 | P00915 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.53 |
| ▸ | IL1RN | P18510 | 1/20 | 0.52 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.52 |
| ▸ | KIF11 | P52732 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30763364 | 0.98 | HPGD (0.65) | HPGDLMNANR3C2HTTSMN1; SMN2 | |
| Acetic Acid SCHEMBL27557152 | 0.92 | HPGD (0.69) | HPGDLMNANR3C2HTTSMN1; SMN2 | |
| SCHEMBL255294 | 0.85 | KEAP1 (0.54) | HPGDLMNANR3C2HTTSMN1; SMN2 | |
| SCHEMBL15672897 | 0.83 | CA2 (0.56) | HPGDLMNANR3C2HTTSMN1; SMN2 | |
| SCHEMBL6533144 | 0.83 | CA1 (0.56) | HPGDLMNANR3C2ARKEAP1 | |
| Hydrochloric Acid SCHEMBL31111910 | 0.83 | KEAP1 (0.52) | HPGDLMNANR3C2HTTSMN1; SMN2 | |
| SCHEMBL4650966 | 0.81 | AR (0.66) | HPGDLMNANR3C2ARKEAP1 | |
| SCHEMBL10443735 | 0.81 | CA2 (0.54) | HPGDLMNANR3C2HTTSMN1; SMN2 | |
| SCHEMBL251932 | 0.80 | AR (0.60) | HPGDLMNANR3C2ARKEAP1 | |
| SCHEMBL8594869 | 0.79 | KEAP1 (0.52) | HPGDLMNANR3C2HTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119101213-A | Preparation process of fiber flame retardant | 绍兴市贝固纺织有限公司 | 2024-12-10 | — | — | CN | claimed |
| US-11279687-B2 | Compounds and compositions for the inhibition of NAMPT | VALO HEALTH, INC. (US) | 2022-03-22 | — | — | US | claimed |
| CN-107779446-B | Immobilized lysine decarboxylase, preparation thereof, preparation method of 1, 5-pentanediamine and product | 上海凯赛生物技术股份有限公司 | 2021-09-07 | — | — | CN | claimed |
| CN-107779445-B | Immobilized lysine decarboxylase, preparation thereof, preparation method of 1, 5-pentanediamine and product | 上海凯赛生物技术股份有限公司 | 2021-02-19 | — | — | CN | claimed |
| US-9169209-B2 | Compounds and compositions for the inhibition of NAMPT | FORMA TM, LLC (US) | 2015-10-27 | — | — | US | claimed |
| US-20140275057-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | Valo Health, LLC | 2014-09-18 | — | — | US | claimed |
| WO-2012150952-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | FORMA TM, LLC (US) | 2012-11-08 | — | — | WO | claimed |
| EP-0333656-A1 | Reactive dyes, process for their preparation and their use | CIBA-GEIGY AG (CH) | 1989-09-20 | — | — | EP | claimed |
| US-4093492-A | HEAT SEALING | PLATE BONN GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1978-06-06 | — | — | US | claimed |
| US-4030957-A | HEAT SEALING | PLATE BONN GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-06-21 | — | — | US | claimed |
| US-3950297-A | HEAT-SEALING AGENTS | PLATE BONN GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1976-04-13 | — | — | US | claimed |
| US-3948844-A | HEAT SEALANTS | PLATE BONN GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1976-04-06 | — | — | US | claimed |
| US-20260078091-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | AMGEN INC (US) | 2026-03-19 | — | — | US | disclosed |
| CN-119101213-A | Preparation process of fiber flame retardant | 绍兴市贝固纺织有限公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-119101213-A | Preparation process of fiber flame retardant | 绍兴市贝固纺织有限公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-114805147-B | Aniline sulfonic acid intermediate for dye and preparation method thereof | 南京晓庄学院 | 2024-09-13 | — | — | CN | disclosed |
| EP-0131302-A2 | Imidazolium salts, intermediates thereto and their use | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-01-16 | — | — | EP | disclosed |
| EP-0073481-A2 | Water-soluble azo compounds, process for their manufacture and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-03-09 | — | — | EP | disclosed |
| EP-0065211-A1 | Azo compounds, process for their preparation and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-11-24 | — | — | EP | disclosed |
| EP-0051808-A2 | Water-soluble monoazo compounds, process for their preparation and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11279687-B2 | Compounds and compositions for the inhibition of NAMPT | NAMPT, NNT, NQO1 | HPGD 199/4885LMNA 419/4885NR3C2 1764/4885 |
| US-20260078091-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | TP53, HIF1AN, MDM2 | HPGD 1074/4885LMNA 738/4885NR3C2 3693/4885 |
| US-20140275057-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | NAMPT, NNMT, NAPRT | HPGD 341/4885LMNA 1255/4885NR3C2 2495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.